🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Expanded Disability Status Scale (EDSS) is the gold-standard in assessi...
Status
Completed
Location
Neurologic Clinic and Policlinic, University Hospital Basel
Start Date
2022-12-09
Trial ID
NCT05575843
Treatments Being Tested
Multiple sclerosis (Latin: Sclerosis multiplex; MS) is a chronic, inflammat...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-01
Trial ID
NCT04533971
Treatments Being Tested
In this study the investigators wish to test the hypothesis that the repert...
Status
Completed
Location
University of Southern California
Start Date
2022-01-29
Trial ID
NCT05171972
Treatments Being Tested
This observational study investigates if switching from MabThera® to Rixath...
Status
Active Not Recruiting
Location
Uppsala University Hospital
Start Date
2025-01-01
Trial ID
NCT07235644
This study aims to develop accessible methods for the early detection of se...
Status
Recruiting
Location
University hospital Olomouc
Start Date
2025-11-01
Trial ID
NCT07360886
Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating, autoimmu...
Status
Unknown
Location
Nigde Omer Halisdemir University
Start Date
2023-11-05
Trial ID
NCT06231030
Treatments Being Tested
The aim of the study is to investigate reliability, validity, and responsiv...
Status
Unknown
Location
Multiple Locations
Start Date
2018-08-05
Trial ID
NCT03584672
1. To investigate the relationship between corticospinal inhibition and cli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-01
Trial ID
NCT07128160
Multiple sclerosis (MS) is a chronic disease of the central nervous system ...
Status
Not Yet Recruiting
Location
CHU de Bordeaux-Hôpital Pellegrin
Start Date
2025-01
Trial ID
NCT06663189
Multiple sclerosis (MS) is a neurodegenerative disease characterized by dem...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT06290453